Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析

◆英語タイトル:Citius Pharmaceuticals Inc (CTXR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH2501101FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥81,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥121,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Mino-Lok, an antibiotic lock solution intended for the treatment of patients with catheter-related bloodstream infections, and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine intended to provide anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. Citius is headquartered in Cranford, New Jersey, the US

Citius Pharmaceuticals Inc Key Recent Developments

Mar 23,2021: Citius Pharmaceuticals to Highlight its Phase 3 Clinical Trial Product Mino-Lok® at Benzinga Biotech Small Cap Conference on March 25
Feb 19,2021: 16:47 ET Citius Pharmaceuticals Announces Closing of $76.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) (“Citius” or the “Company”), a specialty pharmaceutical company focused on de
Jan 25,2021: Citius Pharmaceuticals Announces $20.0 Million Private Placement Priced At-the-Market
Jan 06,2021: Citius Pharmaceuticals to present update on proprietary product candidates at two virtual conferences in January

This comprehensive SWOT profile of Citius Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Citius Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Citius Pharmaceuticals Inc – Key Information
Citius Pharmaceuticals Inc – Overview
Citius Pharmaceuticals Inc – Key Employees
Citius Pharmaceuticals Inc – Key Employee Biographies
Citius Pharmaceuticals Inc – Key Operational Heads
Citius Pharmaceuticals Inc – Major Products and Services
Citius Pharmaceuticals Inc – History
Citius Pharmaceuticals Inc – Company Statement
Citius Pharmaceuticals Inc – Locations And Subsidiaries
Citius Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Citius Pharmaceuticals Inc – Business Description
Citius Pharmaceuticals Inc – Corporate Strategy
Citius Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Citius Pharmaceuticals Inc – Strengths
Citius Pharmaceuticals Inc – Weaknesses
Citius Pharmaceuticals Inc – Opportunities
Citius Pharmaceuticals Inc – Threats
Citius Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Citius Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Citius Pharmaceuticals Inc, Key Information
Citius Pharmaceuticals Inc, Key Ratios
Citius Pharmaceuticals Inc, Share Data
Citius Pharmaceuticals Inc, Major Products and Services
Citius Pharmaceuticals Inc, History
Citius Pharmaceuticals Inc, Key Employees
Citius Pharmaceuticals Inc, Key Employee Biographies
Citius Pharmaceuticals Inc, Key Operational Heads
Citius Pharmaceuticals Inc, Other Locations
Citius Pharmaceuticals Inc, Subsidiaries
Citius Pharmaceuticals Inc, Key Competitors
Citius Pharmaceuticals Inc, SWOT Analysis
Citius Pharmaceuticals Inc, Ratios based on current share price
Citius Pharmaceuticals Inc, Annual Ratios
Citius Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SNGN Romgaz SA (SNG):石油・ガス:M&Aディール及び事業提携情報
    Summary SNGN Romgaz SA (Romgaz), formerly Societatea Nationala de Gaze Naturale Romgaz SA, is an oil and gas company which explores, produces and supplies natural gas. The company's activities include exploration of petroleum onshore and offshore, natural gas production, electric power production, t …
  • Hansen Medical Inc:企業の製品パイプライン分析2018
    Summary Hansen Medical Inc (Hansen Medical), formerly Autocath Inc, a subsidiary of Auris Health Inc, is a medical device company that develops, manufactures and markets magellan robotic system for peripheral vascular intervention. The company’s products comprise robotic system, robotic catheters, s …
  • DISH Network Corp (DISH):企業の財務・戦略的SWOT分析
    DISH Network Corp (DISH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aibel AS:企業の戦略的SWOT分析
    Aibel AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • PT. Indonesia Power:企業の戦略的SWOT分析
    PT. Indonesia Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Dermalogica Inc:企業の戦略・SWOT・財務情報
    Dermalogica Inc - Strategy, SWOT and Corporate Finance Report Summary Dermalogica Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • EndoGastric Solutions Inc-製薬・医療分野:企業M&A・提携分析
    Summary EndoGastric Solutions Inc (EGS), formerly EsophyX, Inc. is a medical equipment company that manufactures and markets gastroenterology and surgical products. The company’s products include esophy-x device and serosa-fuse fasteners. Its esophy-x device is used in reconstructing the gastroesoph …
  • Cancer Genetics Inc (CGIX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic info …
  • IC Group A/S:企業の戦略・SWOT・財務情報
    IC Group A/S - Strategy, SWOT and Corporate Finance Report Summary IC Group A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Banco Bilbao Vizcaya Argentaria Colombia SA:企業の戦略・SWOT・財務分析
    Banco Bilbao Vizcaya Argentaria Colombia SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bilbao Vizcaya Argentaria Colombia SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Tikcro Technologies Ltd (TIKRF):企業の財務・戦略的SWOT分析
    Summary Tikcro Technologies Ltd (Tikcro) is a biotechnology company that discovers, develops, manufactures and markets antibodies. The company undertakes clinical trials for its pipeline products PD1, PDL1, PDL2, TIGIT and CTLA-4 products, among others. Tikcro products are based on 3D antigens desig …
  • Inzpire Limited:企業の戦略・SWOT・財務情報
    Inzpire Limited - Strategy, SWOT and Corporate Finance Report Summary Inzpire Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sanwa Kagaku Kenkyusho Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sanwa Kagaku Kenkyusho Co Ltd (Sanwa), a subsidiary of Suzuken Co Ltd is a contract manufacturing company that conducts research, manufactures and commercializes of pharmaceutical drugs for treating diagnostics, healthcare products, and medical and nursing care nutritionals. The company also …
  • Sherritt International Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Sherritt International Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Sherritt International Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehe …
  • Bracket Global LLC-製薬・医療分野:企業M&A・提携分析
    Summary Bracket Global LLC (Bracket Global) is pharmaceutical company that offers clinical research development services. It strives to bring together science, technology and service to provide superior clinical outcomes for pharmaceutical companies and patients. The company offers services such as …
  • Nanovis Inc-医療機器分野:企業M&A・提携分析
    Summary Nanovis Inc (Nanovis) is a medical device company that develops and markets tissue regenerating implants for bone and soft tissues. The company provides products such as implant nanosurfaces, implantable scaffolds and cervical plate, among others. Nanovis offers products PEEK interbody syste …
  • Grand Gulf Energy Ltd (GGE):石油・ガス:M&Aディール及び事業提携情報
    Summary Grand Gulf Energy Ltd (Grand Gulf Energy), formerly Alto Energy International Ltd, is an oil and gas exploration and production company. The company acquires, explores and develops conventional oil and gas assets in the US oil and gas basins. It holds interests in Napoleonville Salt Dome pro …
  • Allightsykes Pty Ltd
    Allightsykes Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Allightsykes Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ablynx NV (ABLX)-製薬・医療分野:企業M&A・提携分析
    Summary Ablynx NV (Ablynx) is a clinical-stage biopharmaceutical company focused on the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Nanobodies are a novel class of antibody-derived therapeutic proteins which possess structural and functional …
  • Prakash Industries Ltd (PRAKASH):企業の財務・戦略的SWOT分析
    Summary Prakash Industries Ltd (PIL) is a power and steel company. The company’s business activities include mining, steel and power, plastic and wind power. Its mining business division offers explores, acquires and develops iron ore and coal properties. PIL’s steel and power business division prov …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆